NDC 0143-9170 – Starjemza

Ustekinumab 90 mg/mL · Injection · Subcutaneous

Human Prescription Drug

Product NDC0143-9170

Product details

Brand name
Starjemza
Generic name
Ustekinumab-hmny
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
Injection
Route
Subcutaneous
Marketing category
BLA · BLA761419
Marketed since
October 27, 2025
Listing expires
December 31, 2026
Pharmacologic class
Interleukin-12 Antagonist; Interleukin-23 Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Starjemza →

Package NDC codes (1)

Package NDCDescriptionSince
0143-9170-011 mL in 1 SYRINGE (0143-9170-01)Oct 27, 2025

Other Starjemza products